Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

Johnson & Johnson on Tuesday (Sept. 21) shared data that show administering a booster shot of the company’s one-dose COVID-19 vaccine two months after vaccination provides 94% protection against disease, and that waiting even longer to administer the booster increases the extra shot’s effectiveness.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.